LabCorp To Grow In Precision Med With Cancer Diagnostics Lab
Zacks Investment Research | Jun 14, 2017 09:45PM ET
Laboratory Corporation of Americas Holdings (NYSE:LH) , popularly known as LabCorp, has taken major steps to strengthen its foothold in the hugely growing cancer diagnostics space. This life sciences company’s Covance drug development business has recently opened a companion diagnostics laboratory in Morrisville, North Carolina to expand capabilities in precision medicine field.
Being quite a familiar term these days, precision medicine considers individual genes, environment and lifestyle for treatment and prevention of diseases (According to the National Institutes of Health -- NIH).
Per the company, this cutting edge treatment option has a huge scope for improved patient outcome, particularly with targeted therapies and immunotherapies for treatment of cancer. Also, it has scopes in other therapeutic areas and rare diseases.
Companion diagnostics in combination with targeted drugs and therapies help to categorize patients who may or may not benefit from a specific treatment regimen.
The latest development successfully combines Covance’s advanced companion diagnostics capabilities and end-to-end drug development with commercialization capabilities of LabCorp.
Market Prospects
With cancer and other rare diseases spreading like endemics, the huge opportunities for players in this market are clearly visible. Per the latest Global Market Insights report, precision medicine market size was more than $39 billion in 2015, and is projected to grow at a CAGR of 10.5% from 2016 to 2023.
On the other hand, per the Markets and Markets report, the global cancer diagnostics market is expected to reach a worth $13.1 billion by 2020 at a CAGR of 12.9% during 2015-2020. Both these data indicate toward bountiful opportunity that LabCorp may grip through the latest development.
What Others Are Doing
LabCorp’s direct competitor and a leading companion diagnostic player Quest Diagnostics (NYSE:DGX) is also working on the same line. Earlier this week, the company appeared in headlines with the purchase of two laboratories in order to form a precision oncology center in Texas. This center of excellence will provide diagnostic services to detect and manage cancer for oncologists and patients all over the country.
Price Performance
For major part of the last three months, LabCorp traded below the Zacks categorized Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.